NST2060 Case Studies in Drug Development Systems
4 Intermediate Liberal Arts Credits
Drug development is a dynamic, multidisciplinary industry that encompasses the discovery, scientific, clinical and economic assessment of a new compound’s safety, efficacy, potential side effects and requires the collaboration and innovation of scientists, chemists, clinicians, statisticians, lawmakers, business leaders and entrepreneurs. Over the last 30 years, the idealized goal of drug discovery has been to identify a specific chemical substance that is highly specific for a single molecular target and arrests or stems the advancement of disease. Although the goal is highly specific and the process seems linear, there are many contributing, and often unforeseen factors that inform drug design, the drug development pipeline and the eventual success or failure of a given drug candidate. In this course, we will take a systems approach to identify and describe all of the contributing elements of identifying, characterizing and bringing a drug to market, to define the physiological, biological, economic and regulatory systems that characterize the process and to outline the social, economic and environmental considerations of a sustainable and productive model for drug development.
Prerequisites: NST10XX (NST 1)
NST2060: Case Studies in Drug Development Systems
Academic Unit